Jump to navigation
Originally posted by the Dengue Vaccine Initiative.
Today, representatives at the Sixty-fifth World Health Assembly gave their support to a new Global Vaccine Action Plan (GVAP). WHA endorsement of the GVAP marks a major milestone towards universal access to immunization.
This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.
Dengue outbreaks occur in countries throughout the world on an all too frequent basis. One of the latest countries to experience an outbreak of the disease is the Philippines.